• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Octaneuropeptide

Octaneuropeptide

Product ID O0978
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $189.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Octaneuropeptide exhibits anorexigenic activity and may also display epileptogenic potential. Octaneuropeptide is a C-terminal fragment of octadecaneuropeptide, a derivative of diazepam-binding inhibitor (DBI). Octaneuropeptide increases intracellular Ca2+ levels in astrocytes in a PLC-dependent manner.

Product Info

Purity

≥98%

Formula

C41H74N12O11

Formula Wt.

911.1

Solubility

Soluble in water.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

O0978 MSDS PDF

Info Sheet

O0978 Info Sheet PDF

References

Leprince J, Oulyadi H, Vaudry D, et al. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur J Biochem. 2001 Dec;268(23):6045-57. PMID: 11732998.

Vezzani A, Serafini R, Stasi MA, et al. Epileptogenic activity of two peptides derived from diazepam binding inhibitor after intrahippocampal injection in rats. Epilepsia. 1991 Sep-Oct;32(5):597-603. PMID: 1655399.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M1650

    Melanotan II

    Synthetis peptide, melanocortin analog; MCR agonis...
    ≥98%
  • A9814

    AZD-4547

    FGFR inhibitor.
    ≥98%
  • C5968

    Cordycepin

    Nucleoside (deoxyadenosine) analog found in Cordyc...
    ≥98%
  • B3573

    Bisdemethoxycurcumin

    Curcumin derivative; DNMT1 and α-amylase inhibito...
    ≥98%
  • K0652

    Kb NB 142-70

    PKD inhibitor.
    ≥98%
  • M7530

    [Nle4, D-Phe7]-α-Melanocyte Stimulating Hormone

    Semi-synthetic peptide, melanocortin analog; MCR a...
    ≥98%
  • M1873

    S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine

    Sulforaphane-cysteine conjugate.
    ≥98%
  • H2980

    Humanin, human

    Endogenous peptide; FPRL1/2 agonist.
    ≥95%
  • A5276

    Angiotensin I, human

    Endogenous peptide, cleavage product of angiotensi...
    ≥98%
  • R2788

    RGW-611

    Morpholine derivative.
    ≥98%
  • O4658

    Olopatadine Hydrochloride

    Mast cell stabilizer; histamine H1/2/3 antagonist.
    ≥99%
  • J6400

    (+)-JQ-1

    Triazolothienodiazepine; BRD inhibitor.
    ≥99%
  • B0110

    Baclofen

    GABA derivative; GABA-B agonist.
    ≥98%
  • T7134

    trans-3,4′,5-Trimethoxy Stilbene

    Resveratrol prodrug; potential SIRT1 activator.
    ≥98%
  • L0209

    Lactoferrin, cow

    Endogenous glycoprotein; lactoferrin agonist.
    ≥92%
  • G4596

    Glycidamide

    Epoxide metabolite of acrylamide, induces DNA addu...
    ≥98%
  • G7240

    GSK-2830371

    Wip1 inhibitor.
    ≥98%
  • T0002

    T2 Toxin

    Trichothecene mycotoxin produced by Fusarium, alte...
    ≥98%
  • N3208

    Nicardipine

    Dihydropyridine; L-type Ca2+ channel blocker.
    ≥98%
  • A2412

    AGDV

    Peptide fragment of fibrinogen, glycoprotein IIb/I...
    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only